Found: 147
Select item for more details and to access through your institution.
Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging cases.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01441-w
- By:
- Publication type:
- Article
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1462, doi. 10.1002/ajh.27418
- By:
- Publication type:
- Article
Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 336, doi. 10.1002/ajh.27184
- By:
- Publication type:
- Article
Risk of progression in chronic phase‐chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR‐PRO study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1762, doi. 10.1002/ajh.27073
- By:
- Publication type:
- Article
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID‐19.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E470, doi. 10.1002/ajh.26732
- By:
- Publication type:
- Article
Low‐dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E260, doi. 10.1002/ajh.25908
- By:
- Publication type:
- Article
Second cancers in MPN: Survival analysis from an international study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 295, doi. 10.1002/ajh.25700
- By:
- Publication type:
- Article
Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E1, doi. 10.1002/ajh.25644
- By:
- Publication type:
- Article
UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. E283, doi. 10.1002/ajh.25596
- By:
- Publication type:
- Article
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. E239, doi. 10.1002/ajh.25555
- By:
- Publication type:
- Article
Nilotinib induced bone marrow CD34+/lin–Ph+ cells early clearance in newly diagnosed CP‐chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. E162, doi. 10.1002/ajh.25106
- By:
- Publication type:
- Article
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. E159, doi. 10.1002/ajh.25102
- By:
- Publication type:
- Article
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. 615, doi. 10.1002/ajh.25047
- By:
- Publication type:
- Article
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 797, doi. 10.1002/ajh.24774
- By:
- Publication type:
- Article
Early detection of pulmonary hypertension in primary myelofibrosis: The role of echocardiography, cardiopulmonary exercise testing, and biomarkers.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. E47, doi. 10.1002/ajh.24656
- By:
- Publication type:
- Article
Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. E48, doi. 10.1002/ajh.24657
- By:
- Publication type:
- Article
Age and d PCR can predict relapse in CML patients who discontinued imatinib: The ISAV study.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 10, p. 910, doi. 10.1002/ajh.24120
- By:
- Publication type:
- Article
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms An European Leukemia Net study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 11, p. E200, doi. 10.1002/ajh.23809
- By:
- Publication type:
- Article
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 3, p. 306, doi. 10.1002/ajh.23635
- By:
- Publication type:
- Article
Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 2, p. 119, doi. 10.1002/ajh.23593
- By:
- Publication type:
- Article
Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1012268
- By:
- Publication type:
- Article
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231190683
- By:
- Publication type:
- Article
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1799, doi. 10.3390/cancers14071799
- By:
- Publication type:
- Article
Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1311, doi. 10.3390/cancers13061311
- By:
- Publication type:
- Article
Prognostic and Predictive Models in Myelofibrosis.
- Published in:
- Current Hematologic Malignancy Reports, 2024, v. 19, n. 5, p. 223, doi. 10.1007/s11899-024-00739-6
- By:
- Publication type:
- Article
HHV8-Negative Effusion-Based Large B Cell Lymphoma Arising in Chronic Myeloid Leukemia Patients under Dasatinib Treatment: A Report of Two Cases.
- Published in:
- Biology (2079-7737), 2021, v. 10, n. 2, p. 152, doi. 10.3390/biology10020152
- By:
- Publication type:
- Article
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26<sup>+</sup> leukemia stem cells.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1194712
- By:
- Publication type:
- Article
Anagrelide and Mutational Status in Essential Thrombocythemia.
- Published in:
- BioDrugs, 2016, v. 30, n. 3, p. 219, doi. 10.1007/s40259-016-0170-9
- By:
- Publication type:
- Article
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 5, p. 323, doi. 10.1016/j.clml.2024.01.008
- By:
- Publication type:
- Article
CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S329, doi. 10.1016/S2152-2650(21)01772-9
- By:
- Publication type:
- Article
Poster: CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S225, doi. 10.1016/S2152-2650(21)01419-1
- By:
- Publication type:
- Article
Dropled Digital PCR May Have a Prognostic Value for Predicting Relapse after Imatinib Discontinuation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S62, doi. 10.1016/j.clml.2016.07.090
- By:
- Publication type:
- Article
Essential Thrombocythemia: The Dermatologic Point of View.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Biological Determinants of Long-Term Survival in Chronic Myelogenous Leukemia Patients Treated with Conventional Chemotherapy.
- Published in:
- Acta Haematologica, 1997, v. 97, n. 3, p. 187, doi. 10.1159/000203679
- By:
- Publication type:
- Article
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 12, p. 1720, doi. 10.1007/s11864-023-01149-1
- By:
- Publication type:
- Article
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 7, p. 802, doi. 10.1007/s11864-023-01099-8
- By:
- Publication type:
- Article
Management of Myelofibrosis: from Diagnosis to New Target Therapies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 5, p. 383, doi. 10.1002/ajh.20579
- By:
- Publication type:
- Article
Polycythemia vera treated with recombinant interferon-alpha 2a: Evidence of a selective effect on the malignant clone.
- Published in:
- American Journal of Hematology, 1997, v. 56, n. 2, p. 126, doi. 10.1002/(SICI)1096-8652(199710)56:2<126::AID-AJH10>3.0.CO;2-A
- By:
- Publication type:
- Article
Osteolytic Lesions in Primary Myelofibrosis and Effect of Ruxolitinib Therapy: Report of a Case and Literature Review.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 6, p. 340, doi. 10.1159/000497246
- By:
- Publication type:
- Article
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00834-6
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Breakthrough infections in MPN-COVID vaccinated patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00749-8
- By:
- Publication type:
- Article
Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Long-term follow-up of recovered MPN patients with COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00445-z
- By:
- Publication type:
- Article
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0333-2
- By:
- Publication type:
- Article
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 6, p. 1, doi. 10.1038/s41419-022-05028-9
- By:
- Publication type:
- Article